n(1)-methylnicotinamide has been researched along with Chronic Kidney Failure in 2 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nasseri, K | 1 |
| Daley-Yates, PT | 2 |
| Maiza, A | 1 |
2 other studies available for n(1)-methylnicotinamide and Chronic Kidney Failure
| Article | Year |
|---|---|
A comparison of N-1-methylnicotinamide clearance with 5 other markers of renal function in models of acute and chronic renal failure.
Topics: Acetylglucosaminidase; Acute Kidney Injury; Animals; Biomarkers; Kidney Failure, Chronic; Kidney Tub | 1990 |
Estimation of the renal clearance of drugs using endogenous N-1-methylnicotinamide.
Topics: Acute Kidney Injury; Animals; Cephalexin; Cimetidine; Glomerular Filtration Rate; Inulin; Kidney; Ki | 1990 |